CA
NZ
UK
AU
IND
US
● Modular Medical develops the Pivot tubeless insulin patch pump, a wearable system that delivers continuous basal and bolus insulin over a three-day wear period, with a removable reservoir, a disposable battery and smartphone connectivity.
Medtronic plc (NYSE:MDT) heads into the back half of 2026 looking less like a name in transition and more like one quietly regaining its footing. A raised fiscal 2027 outlook, delivered alongside a roughly $700 million robotics partnership, gave investors two fresh reasons to …
● MediWound has spent 2026 building a quietly compelling case as a specialist in tissue repair and wound care, and its Nasdaq-listed shares reflect that trajectory near $14 with a marketCapitalizationaround $180 million.
A commercial-stage diagnostics company can post double-digit revenue growth and still find its shares under a dollar, a tension that defines MDxHealth SA (NASDAQ: MDXH) heading into autumn 2026. The Nasdaq-listed molecular diagnostics group has built a growing prostate-cancer testing franchise, yet a sliding …
Few small-cap health-tech stories have shifted direction as sharply as Mangoceuticals, Inc. (NASDAQ: MGRX), the telemedicine company now attempting to reinvent itself through a proposed pivot into nuclear technology. As September 2026 unfolds, the Nasdaq-listed men's-health platform is juggling a looming listing-compliance deadline, a …
Manhattan Scientifics, Inc (OTC:MHTX) is the kind of long-lived, technology-focused micro-cap that periodically resurfaces in speculative trading chatter, and the ticker has drawn renewed attention after a sharp move. The framing warrants an important caveat up front: in an over-the-counter name quoted at a …
Meihua International Medical Technologies (OTC:MHUAF) is a name that now sits well off the radar of most U.S. investors, and for good reason. The China-based medical-device manufacturer was pushed off the Nasdaq in late 2025 and now changes hands in the over-the-counter market, where …
● Milestone Pharmaceuticals is a biopharmaceutical company focused on cardiovascular conditions, led by etripamil, a calcium channel blocker delivered as a nasal spray for paroxysmal supraventricular tachycardia, or PSVT, a rapid heart-rhythm disorder.
Before reading anything into a double-digit percentage swing, it is worth knowing what actually sits behind the ticker. Lotus Pharmaceuticals, Inc (OTC: LTUS) is not a conventional, exchange-listed operating company but a sub-penny stock trading on the OTC market and described by data providers …
MabCure, Inc (OTC:MBCI) is the kind of obscure micro-cap that rarely surfaces outside of ticker screens, yet its focus, antibody-based early cancer detection, touches one of medicine's most sought-after goals. The reality behind MBCI is far more modest: a tiny development-stage company that has …
Please wait processing your request...